Skip to main content
Victoza-H-C-1026-PSUSA-00001892- 201512: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation

Victoza-H-C-1026-PSUSA-00001892- 201512: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation

2 wyświetleń
Pobierz
Farmaceutyczny

Victoza-H-C-1026-PSUSA-00001892- 201512: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation

Zaawansowana formuła farmaceutyczna do celowanego działania terapeutycznego.

Dawkowanie

Victoza-H-C-1026-PSUSA-00001892- 201512: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation

Moc

Victoza-H-C-1026-PSUSA-00001892- 201512: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation

Wielkość opakowania

Victoza-H-C-1026-PSUSA-00001892- 201512: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation

Postać

Victoza-H-C-1026-PSUSA-00001892- 201512: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation

Źródło

European Medicines Agency

Zobacz źródło

Profil bezpieczeństwa

Przeciwwskazania

Victoza-H-C-1026-PSUSA-00001892- 201512: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation

Skutki uboczne

Victoza-H-C-1026-PSUSA-00001892- 201512: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation

Powiązane artykuły kliniczne

Skanuj ten kod QR, aby szybko uzyskać dostęp do tej strony na swoim urządzeniu mobilnym.

QR Code